Evidence map›Paper›PMID 41898659›Full record

ArticleInternational journal of molecular sciences2026

The Complex of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow.

Elena S Barskaya, Artemii M Savin, Kirill V Chernov, Albina S Petrova, Maksim S Abramovich, Yulia A Maksimova, Alexander S Dubenskiy, Sergey A Tsymbal, Anna V Lantsova, Anna A Moiseeva and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elena S BarskayaDepartment of Chemistry, Moscow State University, 1/3 Leninskie Gory, Moscow 119991, Russia.ORCID 0009-0007-7654-1486
Artemii M SavinCenter for Molecular and Biological Technologies, ITMO University, 9 Lomonosov Street, Saint-Petersburg 197101, Russia.
Kirill V ChernovCenter for Molecular and Biological Technologies, ITMO University, 9 Lomonosov Street, Saint-Petersburg 197101, Russia.
Albina S PetrovaInstitute of Medicine, RUDN University, 6 Miklukho-Maklaya Street, Moscow 117198, Russia.ORCID 0000-0001-7898-5565
Maksim S AbramovichDepartment of Chemistry, Moscow State University, 1/3 Leninskie Gory, Moscow 119991, Russia.
Yulia A MaksimovaLaboratory of Chemical Analytical Research, Geological Institute of Russian Academy of Sciences, 7 Pyzhevsky Lane Bld. 1, Moscow 119017, Russia.ORCID 0000-0001-8546-2279
Alexander S DubenskiyLaboratory of Chemical Analytical Research, Geological Institute of Russian Academy of Sciences, 7 Pyzhevsky Lane Bld. 1, Moscow 119017, Russia.ORCID 0000-0001-9364-5876
Sergey A TsymbalCenter for Molecular and Biological Technologies, ITMO University, 9 Lomonosov Street, Saint-Petersburg 197101, Russia.
Anna V LantsovaInstitute of Experimental Oncology and Carcinogenesis, Blokhin National Research Center of Oncology, 24 Kashirskoye Shosse, Moscow 115522, Russia.ORCID 0000-0002-0650-2023
Anna A MoiseevaDepartment of Chemistry, Moscow State University, 1/3 Leninskie Gory, Moscow 119991, Russia.
Maria A BeloglazkinaDepartment of Chemistry, Moscow State University, 1/3 Leninskie Gory, Moscow 119991, Russia.
Roman S BorisovA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, 29 Leninsky Avenue, Moscow 119071, Russia.
Elena K BeloglazkinaDepartment of Chemistry, Moscow State University, 1/3 Leninskie Gory, Moscow 119991, Russia.ORCID 0000-0001-6796-8241
Alexander A ShtilInstitute of Experimental Oncology and Carcinogenesis, Blokhin National Research Center of Oncology, 24 Kashirskoye Shosse, Moscow 115522, Russia.

Funding

Non-Commercial Foundation for Support of Oncology Research (RakFond) agreement 1/2024 July 30, 2024Russian Science Foundation No. 25-75-10075
6 · The paper itself

Abstract

Copper-organic compounds are being investigated as antitumor candidates. Besides their efficacy as cytotoxic agents alone, the oxidative potential of electrochemical Cu

Indexed as

Antineoplastic AgentsBone MarrowCoordination ComplexesCopperLeukemiaZoledronic AcidCell DeathCell Line, TumorHumansK562 CellsOxidation-ReductionAntineoplastic AgentsCoordination ComplexesCopperZoledronic Acidcell deathcopperelectrochemistrymedicinal chemistryredox reactionszoledronic acid

Identifiers

PMID41898659
PMCPMC13026577

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.